Social media: Why AASLD and its members must lead the conversation

Heller, Theo; Koh, Christopher; Kumar, Sonal

doi:10.1002/hep.29916

Cited by 4 publications

(5 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As physicians, we must be diligent in guiding our patients by highlighting the risks and benefits that come with accepting an HCV-positive donor and providing adequate informed consent . One of the potential avenues to accomplish this task is by using social media as a way to disseminate knowledge about the use of HCV-positive donors to physicians and patients across the country, remove the social stigma around the use of HCV-positive grafts, and improve perception …”

Section: Discussionmentioning

confidence: 99%

“…21 One of the potential avenues to accomplish this task is by using social media as a way to disseminate knowledge about the use of HCV-positive donors to physicians and patients across the country, remove the social stigma around the use of HCV-positive grafts, and improve perception. 31,32…”

Section: Jama Network Open | Gastroenterology and Hepatologymentioning

confidence: 99%

“…From June 1, 2015, to December 1, 2018, a total of 24 500 donors were used for LT, of which 1887 Compared with HCV Ab-negative donors, HCV Ab-positive donors were younger (median [IQR] age, 35 [29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46] years vs 40 years; P < .001), had fewer comorbidities, such as diabetes (8.3% vs 12.0%; P < .001) and hypertension (25.9% vs 35.2%; P < .001), and were more likely to be White (81.0% vs 63.2%; P < .001) (Table 1). HCV Ab-positive donors were also more likely to have a history of heavy alcohol and tobacco use, cocaine use, and other drug abuse.…”

Section: The Trend Of Hcv Positive Donorsmentioning

confidence: 99%

See 2 more Smart Citations

Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation

Ezaz

Kushner

et al. 2020

JAMA Netw Open

View full text Add to dashboard Cite

IMPORTANCEIncreased utilization of hepatitis C virus (HCV)-positive liver allografts for liver transplant (LT) has been endorsed as one of several ways to combat national organ shortages. However, HCV-positive donors remain poorly characterized, and Organ Procurement and Transplantation Network regional differences in the utilization of HCV-positive liver allografts are unclear. OBJECTIVE To characterize HCV-positive donors and the allografts that come from them. DESIGN, SETTING, AND PARTICIPANTS In this cross-sectional study, the Scientific Registry of Transplant Recipients database was queried for all donors who underwent HCV testing from June 2015 to December 2018. Clinical and allograft characteristics were evaluated, and utilization across the United States was studied. Patients with positive or negative results for HCV antibody (Ab) and HCV nucleic acid amplification testing (NAT) were included in this study. Donors utilized for living donor transplant and pediatric (age <18 years) recipients were excluded.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Jama Network Open | Gastroenterology and Hepatologymentioning

confidence: 99%

Section: The Trend Of Hcv Positive Donorsmentioning

confidence: 99%

See 1 more Smart Citation

Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation

Ezaz

Kushner

et al. 2020

JAMA Netw Open

View full text Add to dashboard Cite

show abstract

“…In 2018, we challenged the readers of HEPATOLOGY to lead the international conversation about hepatology on social media. ( 1 ) and you stepped up. The American Association for the Study of Liver Diseases (AASLD) has seen a near doubling of Facebook followers since 2017 (6,173 to 12,047) and an even greater increase in Twitter followers over the same period (7,649 to over 19,000).…”

mentioning

confidence: 99%

Professional Use of Social Media by Hepatology Providers

2021

Self Cite

View full text Add to dashboard Cite

“…Thus far, the use of Twitter as a research modality has not been studied in hepatology. Given the increasing trends of social media use in medicine, the American Association for the Study of Liver Diseases (AASLD) has advocated for the increased use of social media to “advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care.” The AASLD Twitter handle has become a regular source of key information regarding hepatology news and currently has over 13,000 followers (https://twitter.com/AASLDtweets). The other major liver societies also have their respective Twitter handles: European Association for the Study of the Liver (https://twitter.com/EASLnews) with over 8,700 followers and Asian Pacific Association for the Study of the Liver (https://twitter.com/APASLnews) with over 400 followers.…”

mentioning

confidence: 99%

Twitter As a Noninvasive Bio‐Marker for Trends in Liver Disease

Surana

Schueler

et al. 2019

Hepatol Commun

Self Cite

View full text Add to dashboard Cite

With the success of hepatitis C virus (HCV) direct‐acting antiviral therapies, there has been a shift in research focus to the other major chronic liver diseases (CLDs). The use of social media, specifically Twitter, has become a popular platform for understanding public health trends and for performing health care research. To evaluate this, we studied the areas of public interest and social media trends of the following three major CLDs: hepatitis B virus (HBV), HCV, and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH). Twitter activity data from January 1, 2013, through January 1, 2019, for HBV, HCV, and NAFLD/NASH were collected using the social media analytic tool Symplur Signals (Symplur LLC) software. Content and regression analyses were performed to understand and predict Twitter activity for each of the CLDs. Over the study period, there were 810,980 tweets generating 4,452,939,516 impressions. HCV tweet activity peaked in 2015 at 243,261 tweets, followed by a decline of 52.4% from 2015 to 2016 with a subsequent plateau through 2018. Meanwhile, NAFLD/NASH and HBV tweet activity has continued to increase, with projections that these two CLDs will surpass HCV by the second half of 2023 and 2024, respectively. Treatment and Management was the most popular content category for HCV and NAFLD/NASH, while Prevention was the most popular content category for HBV. Conclusion: Twitter is a useful social media tool to gauge public interest in liver disease over time. The information provided by Twitter can be used to identify gaps in public knowledge or highlight areas of interest that may need further research. Future studies on the use of Twitter in liver disease are warranted.

show abstract

Social media: Why AASLD and its members must lead the conversation

Cited by 4 publications

References 3 publications

Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation

Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation

Professional Use of Social Media by Hepatology Providers

Twitter As a Noninvasive Bio‐Marker for Trends in Liver Disease

Contact Info

Product

Resources

About